These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Method of specimen collection for histological examinations in obliterating vascular diseases of the lower limbs]. Pospishil' IuA, Erdmanis DF. Arkh Patol; 1982; 44(11):74-6. PubMed ID: 7159242 [Abstract] [Full Text] [Related]
6. [Inter-related arterial and venous pathologies]. Bastide G, Barret A, Lefebvre D. Phlebologie; 1992; 45(4):367-71. PubMed ID: 1302311 [Abstract] [Full Text] [Related]
7. [Histological distinction between thrombo-angiitis obliterans and arteriosclerosis]. Leu HJ, Brunner U. Dtsch Med Wochenschr; 1973 Jan 26; 98(4):158-61. PubMed ID: 4684012 [No Abstract] [Full Text] [Related]
8. [Histologic, immunohistologic and enzyme histochemical findings in endangitis obliterans]. Lambrecht R, Spormann H, Franke B, Morenz J, Heinrich P. Vasa; 1985 Jan 26; 14(1):10-5. PubMed ID: 3156453 [No Abstract] [Full Text] [Related]
9. Thromboangiitis obliterans in a woman. Report of a case. Zelikovsky A, Urca I, Kessler E. Angiology; 1973 Mar 26; 24(3):169-74. PubMed ID: 4694885 [No Abstract] [Full Text] [Related]
10. Thromboangiitis obliterans associated with coeliac disease. Durand JM, Lefevre P, Kaplanski G, Quiles N, Branchereau A, Soubeyrand J. Cardiovasc Surg; 1993 Jun 26; 1(3):273-5. PubMed ID: 8076045 [Abstract] [Full Text] [Related]
11. [Clinical manifestation of thrombendangiitis obliterans of the central nervous system]. Lahl R, Kissig B. Z Gesamte Inn Med; 1984 Oct 01; 39(19):474-7. PubMed ID: 6516488 [Abstract] [Full Text] [Related]
15. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene by Leo Buerger, M.D.: published, 1908 in the American Journal of the Medical Sciences. Am J Med Sci; 1973 Oct 01; 266(4):278-91. PubMed ID: 4585906 [No Abstract] [Full Text] [Related]
17. [On the use of 2-beta-hydroxyphenetylaminopyridine 1-(p-hydroxyphenyl)-2-phenyl-3-hydroxy-4-n-butyl-5-pyrazolinonate in venous and arterial vasculopathies]. Gazzaniga M, Aulisa B, Maconi F. Minerva Cardioangiol; 1967 Mar 01; 15(5):343-52. PubMed ID: 5603840 [No Abstract] [Full Text] [Related]